Lupin launches generic drug to treat urea cycle disorders in US

Drug firm Lupin has launched a generic medication in the US. This new drug treats urea cycle disorders. It is an authorized generic version of Ravicti oral liquid. The medication helps patients manage the disorder. This is for those who cannot be managed by diet alone. Lupin's shares saw a slight dip on the BSE.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/StLxhry
via IFTTT